Pregnancy Outcome and Safety of Interrupting Therapy for women
with endocrine responsIVE breast cancer: Primary Results from the POSITIVE Trial (IBCSG 48-14 / BIG 8-13)
- Citation:
- Cancer Research vol 83 (5_suppl) abst GS4-09
- Meeting Instance:
- SABCS 2022
- Year:
- 2023
- Type:
- Abstract
- Sub type:
- Oral
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 3890
- Program:
- CCP
- Primary Committee:
- Symptom Inter
- Sec. Committees:
- Breast
- Pharmas:
- Grants:
- UG1CA189823
- Corr. Author:
- Authors:
- Ann H Partridge Samuel M Niman Monica Ruggeri Fedro A Peccatori Hatem A Azim Jr. Marco Colleoni Cristina Saura Chikako Shimizu Anna Barbro Sætersdal Judith R Kroep Audrey Mailliez Ellen Warner Virginia F Borges Frédéric Amant Andrea Gombos Akemi Kataoka Christine Rousset-Jablonski Simona Borstnar Junko Takei Jeong Eon Lee Janice M Walshe Manuel Ruíz Borrego Halle CF Moore Christobel Saunders Vesna Bjelic-Radisic Snezana Susnjar Fatima Cardoso Karen L Smith Teresa Ferreiro Karin Ribi Kathryn J Ruddy Sarra El-Abed Martine Piccart Larissa A Korde Aron Goldhirsch Richard D Gelber Olivia Pagani
- Networks:
- LAPS-CO070, LAPS-MA036, LAPS-MD017, LAPS-MN026, OH027
- Study
- Alliance-A221405
- Multiple Studies, or Legacy Studies in Alliance Study:
- IBSCG 48-14
- Phases:
- N/A, N/A
- Keywords: